As the nutraceutical market rapidly advances towards improved bioavailability and innovative delivery methods, formulation technology has become increasingly crucial for enhancing product performance. Today’s formulators and brand developers face a common challenge: selecting the right delivery platform from an increasingly diverse array of advanced systems. Each technology offers its own advantages and compromises related to cost, complexity, stability, release kinetics, and compatibility with specific dosage forms. Recognizing these differences can help ensure that an ingredient not only performs well on paper but also delivers effective results in the final product.
This guide compares four key technologies from Pharmako Biotechnologies: AquaCelle®, LipiSperse®, and PlexoZome®, outlining where each excels, and helping developers make informed, efficient, and commercially sound formulation decisions.
AquaCelle®: For Liquids, Emulsions, and Self-Emulsifying Softgels
AquaCelle® is a self-micro-emulsifying delivery system (SMEDS) designed to transform lipophilic oils into water-dispersible systems that enhance absorption and bioavailability. It excels in liquid and softgel applications where clarity, stability, and fast absorption are top priorities. This makes it particularly useful for lipid-based ingredients such as Omega-3 oils, CoQ10, tocotrienols, and carotenoids.
Formulators value AquaCelle® for its ability to create clear, shelf-stable dispersions without synthetic solubilizers. It integrates seamlessly into existing manufacturing lines and performs reliably under standard heat conditions. Although slightly more complex to formulate than dry systems, AquaCelle® provides a strong return on investment for brands aiming at high-bioavailability liquid or softgel formats with quick absorption profiles.
LipiSperse®: For Powders, Tablets, and Functional Foods
LipiSperse® was created to address a common problem with lipophilic active ingredients: poor dispersibility in aqueous environments. This solid lipid dispersion technology ensures that ingredients such as curcumin, lutein, and resveratrol stay evenly distributed, making them more bioavailable and stable in powder or tablet matrices.
This system is especially suitable for dry dosage forms like sachets, stick packs, drink mixes, and chewables. Its compatibility with standard powder processing makes scaling up straightforward, while its stability in dry form offers clear advantages over emulsion-based systems. LipiSperse® has shown significant improvements in absorption across multiple actives, allowing formulators to achieve better performance at lower doses. Although it might not be ideal for pure oil or clear liquid applications, it performs best where solid stability and easy manufacturing are essential.
PlexoZome®: For Targeted Delivery and Sensitive Actives
For developers working with delicate compounds, PlexoZome® provides an advanced liposomal encapsulation platform that improves both stability and bioavailability. By trapping active compounds within bilayer vesicles, PlexoZome® shields them from environmental stressors like oxidation, pH fluctuations, and enzymatic breakdown. This makes it perfect for sensitive ingredients such as vitamin C, polyphenols, and peptides that can easily lose potency in traditional formulations.
PlexoZome® also supports controlled and sustained release, enabling precise delivery kinetics. It integrates well with both liquid and powder systems, although its production requires a higher level of technical expertise and investment. The benefits are substantial: products using PlexoZome® can legitimately claim superior stability, enhanced absorption, and even targeted cellular delivery. This makes it the preferred choice for premium formulations that focus on science-backed efficacy.
Choosing the Right Technology
Each of these technologies serves a distinct function within the formulation toolbox. AquaCelle® is ideal for liquids and self-emulsifying softgels that demand clarity and high absorption. LipiSperse® performs best in powder and tablet systems where stability and easy scale-up matter most. PlexoZome® stands out for protecting fragile compounds and supporting advanced delivery claims.
In many cases, a hybrid strategy can be particularly effective, for example, using LipiSperse® for powdered formats and AquaCelle® for companion liquid SKUs. This approach enables brands to maintain consistent bioavailability across various delivery forms, ensuring that the consumer experience and clinical efficacy align.
Putting a Bow on Technologies
Advanced delivery technologies are no longer niche solutions; they’re essential tools for modern product development. By matching the right platform to the desired dosage form, stability needs, and market positioning, formulators can build products that truly stand out. AquaCelle®, LipiSperse®, and PlexoZome® each bring unique advantages to the table, offering multiple pathways to improved performance, cleaner labels, and greater consumer satisfaction.
For brands seeking to innovate with confidence, understanding these distinctions is the first step toward more informed formulation and enhanced market differentiation.